Intratumoral and peritumoral MRI habitat imaging for differentiating stage IA endometrial cancer from benign endometrial lesions: a multicenter study - Report - MDSpire

Intratumoral and peritumoral MRI habitat imaging for differentiating stage IA endometrial cancer from benign endometrial lesions: a multicenter study

  • By

  • Yunzhu Wu

  • Xianhong Wang

  • Cheng Deng

  • Qiu Bi

  • Yang Song

  • Shenghong Ju

  • Yang Liu

  • Conghui Ai

  • Jing Yang

  • July 9, 2026

  • 0 min

Share

Clinical Report: MRI Habitat Imaging for Distinguishing Stage IA Endometrial Cancer

Overview

This study evaluates multiparametric MRI-based radiomics models for differentiating stage IA endometrial cancer from benign lesions.

Background

Endometrial carcinoma is a common gynecological cancer with increasing incidence. Accurate preoperative differentiation between stage IA endometrial cancer and benign lesions is crucial for treatment decisions. Traditional diagnostic methods are invasive and may not be applicable to all patients.

Data Highlights

ModelValidation AUC
Clinical Model0.644
Clinical + K-means_RD30.921
K-means_RD30.740

Key Findings

  • Age and vaginal bleeding are independent predictors of stage IA endometrial cancer.
  • Habitat-based models outperformed clinical models in external validation cohorts.
  • The Clinical + K-means_RD3 model achieved the highest diagnostic performance with a peak AUC of 0.921.
  • K-means demonstrated superior robustness compared to Gaussian Mixture Model (GMM).
  • Peritumoral features, particularly K-means_RD3, showed favorable robustness.

Clinical Implications

This study presents findings on the integration of habitat imaging with clinical predictors.

Conclusion

Multiparametric MRI habitat imaging can differentiate stage IA endometrial cancer from benign lesions.

Related Resources & Content

  1. European Radiology, 2025 -- Advancements in MRI Utilization for Rectal Cancer
  2. European Radiology, 2019 -- 3D Imaging as a Promising Method for Staging Upper Tract Urothelial Carcinoma
  3. Frontiers in Oncology, 2026 -- CT-based habitat imaging for noninvasive prediction of microvascular invasion in hepatocellular carcinoma
  4. RadioGraphics, 2023 -- Update: 2023 FIGO Staging System for Endometrial Cancer
  5. European Radiology — Imaging Hypoxia and Vascular Dynamics in ER-Positive Breast Cancer Using PET/MRI: Links to Immunohistochemical Findings
  6. ESGO Pocket Guidelines for Endometrial Carcinoma
  7. PubMed - MRI-based intratumoral and peritumoral radiomics
  8. Checking your browser - reCAPTCHA
  9. RadioGraphics Update: 2023 FIGO Staging System for Endometrial Cancer | RadioGraphics
  10. Frontiers | MRI-based intratumoral and peritumoral radiomics for assessing deep myometrial invasion in patients with early-stage endometrioid adenocarcinoma
  11. https://kjronline.org/pdf/10.3348/kjr.2025.0633
  12. Prediction of molecular subtypes of endometrial cancer patients on the basis of intratumoral and peritumoral radiomic features from multiparametric MR images
  13. Radiomics-Based Machine Learning for the Detection of Myometrial Invasion in Endometrial Cancer: Systematic Review and Meta-Analysis - PubMed

Original Source(s)

Intratumoral and peritumoral MRI habitat imaging for differentiating stage IA endometrial cancer from benign endometrial lesions: a multicenter study

  • by Yunzhu Wu, Xianhong Wang, Cheng Deng, Qiu Bi, Yang Song, Shenghong Ju, Yang Liu, Conghui Ai, Jing Yang

  • July 9, 2026

Related Content

Telepresence avatar use for children with cancer in schools: a study on barriers and facilitators

The 1α,25-dihydroxyvitamin D3 modulates T cell activation and immune checkpoint pathways in human T cells

Smart FL: meta-learning for federated blood marrow smear classification